XML 50 R39.htm IDEA: XBRL DOCUMENT v3.22.2.2
Collaboration Agreements And Business Development Activities - GSK Narrative (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2022
Oct. 01, 2021
Sep. 30, 2022
Oct. 01, 2021
Collaboration Agreement with GlaxoSmithKline        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Percent of royalty on net sale     3.00%  
Royal Pharma        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Royalty expense $ 14.9 $ 11.5 $ 42.6 $ 33.7